Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Awakn Life Sciences Corp (AWKNF)

Awakn Life Sciences Corp (AWKNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0779 +21.82%
on 10/23/24
0.1200 -20.92%
on 11/15/24
+0.0272 (+40.18%)
since 10/22/24
3-Month
0.0550 +72.55%
on 10/04/24
0.1200 -20.92%
on 11/15/24
-0.0052 (-5.19%)
since 08/22/24
52-Week
0.0487 +94.87%
on 07/08/24
0.1877 -49.44%
on 04/09/24
+0.0399 (+72.55%)
since 11/22/23

Most Recent Stories

More News
Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites

Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)
Awakn Partners with the University of Nottingham for in Vivo Testing of Aminoindane New Chemical Entity (NCE) Pre-Clinical Program

Toronto, Ontario--(Newsfile Corp. - October 15, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)
Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program

Toronto, Ontario--(Newsfile Corp. - October 4, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company focused on developing...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)
Awakn Life Sciences Announces Upsizing and Closing of Tranche of Private Placement Financing

Toronto, Ontario--(Newsfile Corp. - September 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)
Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program

Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF), a clinical-stage biotechnology company developing therapeutics for substance use and mental...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)
Awakn Announces First Patient Screened in Phase 3 Clinical Trial of AWKN-001 for Severe Alcohol Use Disorder

Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)
Awakn Life Sciences Announces Closing of Tranche of Private Placement and Warrant Extension

Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)
Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio

Toronto, Ontario--(Newsfile Corp. - July 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)
Awakn Life Sciences Announces Collaboration Agreement with Graft Polymer (UK) PLC

Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)
Awakn Life Sciences Announces Closing of Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - June 4, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0949 (+7.84%)
AWKN.CN : 0.1200 (+9.09%)

Key Turning Points

3rd Resistance Point 0.0949
2nd Resistance Point 0.0949
1st Resistance Point 0.0949
Last Price 0.0949
1st Support Level 0.0949
2nd Support Level 0.0949
3rd Support Level 0.0949

See More

52-Week High 0.1877
Fibonacci 61.8% 0.1346
Fibonacci 50% 0.1182
Fibonacci 38.2% 0.1018
Last Price 0.0949
52-Week Low 0.0487

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar